Literature DB >> 21716588

Tool for guidance: evidence-based recommendations for managing febrile neutropenia.

Andrew J Ullmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21716588      PMCID： PMC3110844          DOI： 10.3904/kjim.2011.26.2.135

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN： 1226-3303            Impact factor:   2.884


× No keyword cloud information.
  4 in total

1.  The periodic health examination. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

2.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-01-04       Impact factor: 9.079

Review 3.  Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations.

Authors:  J L Brożek; E A Akl; E Compalati; J Kreis; L Terracciano; A Fiocchi; E Ueffing; J Andrews; P Alonso-Coello; J J Meerpohl; D M Lang; R Jaeschke; J W Williams; B Phillips; A Lethaby; P Bossuyt; P Glasziou; M Helfand; J Watine; M Afilalo; V Welch; A Montedori; I Abraha; A R Horvath; J Bousquet; G H Guyatt; H J Schünemann
Journal:  Allergy       Date:  2011-01-17       Impact factor: 13.146

Review 4.  Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.

Authors:  Dong-Gun Lee; Sung-Han Kim; Soo Young Kim; Chung-Jong Kim; Wan Beom Park; Young Goo Song; Jung-Hyun Choi
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 3.165
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.